In vivo inhibition of angiotensin converting enzyme and neutral endopeptidase by a dual vasopeptidase inhibitor

被引：0
|
作者：
Burrell, LM
Rockell, MD
Powell, J
Johnston, CI
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
[2] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
来源：
AMERICAN JOURNAL OF HYPERTENSION | 1999年 / 12卷 / 04期
关键词：
vasopeptidase inhibitors; omapatrilat; angiotensin; natriuretic peptides;
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：119A / 119A
页数：1
相关论文
共 50 条
  • [21] Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes
    Tikkanen, I
    Tikkanen, T
    Cao, ZM
    Allen, TJ
    Davis, BJ
    Lassila, M
    Casley, D
    Johnston, CI
    Burrell, LM
    Cooper, ME
    JOURNAL OF HYPERTENSION, 2002, 20 (04) : 707 - 714
  • [22] ANTIHYPERTENSIVE ACTIVITY DURING INHIBITION OF NEUTRAL ENDOPEPTIDASE AND ANGIOTENSIN CONVERTING ENZYME
    SEYMOUR, AA
    SWERDEL, JN
    ABBOAOFFEI, B
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 (03) : 456 - 465
  • [23] Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats
    Pu, Q
    Larouche, I
    Schiffrin, EL
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (11) : 931 - 937
  • [24] Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors
    Seymour, AA
    Asaad, MM
    AbboaOffei, BE
    Smith, PL
    Rogers, WL
    Dorso, CR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 276 (02): : 708 - 713
  • [25] Design and pharmacology of dual angiotensin-converting enzyme and neutral endopeptidase inhibitors
    DeLombaert, S
    Chatelain, RE
    Fink, CA
    Trapani, AJ
    CURRENT PHARMACEUTICAL DESIGN, 1996, 2 (05) : 443 - 462
  • [26] Neutral endopeptidase/angiotensin converting enzyme inhibition attenuates remodelling in heart failure
    Farina, NK
    Johnston, CI
    Burrell, LM
    JOURNAL OF HYPERTENSION, 1998, 16 : S34 - S34
  • [27] DUAL INHIBITION OF ANGIOTENSIN-CONVERTING ENZYME AND NEUTRAL ENDOPEPTIDASE BY THE ORALLY-ACTIVE INHIBITOR MIXANPRIL - A POTENTIAL THERAPEUTIC APPROACH IN HYPERTENSION
    FOURNIEZALUSKI, MC
    GONZALEZ, W
    TURCAUD, S
    PHAM, I
    ROQUES, BP
    MICHEL, JB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 4072 - 4076
  • [28] DIASTEREOSELECTIVE SYNTHESIS OF MIXANPRIL, AN ORALLY-ACTIVE DUAL INHIBITOR OF NEUTRAL ENDOPEPTIDASE AND ANGIOTENSIN-CONVERTING ENZYME
    TURCAUD, S
    GONZALEZ, W
    MICHEL, JB
    ROQUES, BP
    FOURNIEZALUSKI, MC
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (17) : 1893 - 1898
  • [29] Neutral endopeptidase inhibitor versus angiotensin converting enzyme inhibitor in a rat model of the metabolic syndrome
    Eizenberg, Yoav
    Grossman, Ehud
    Peleg, Edna
    Shabtai, Zehava
    Sharabi, Yehonatan
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2014, 8 (04) : 227 - 231
  • [30] Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase 24.11.
    Chatelain, RE
    Odorico, LM
    Ghai, RD
    Trapani, AJ
    Fink, CA
    Lappe, RW
    FASEB JOURNAL, 1996, 10 (03): : 4038 - 4038
12345